Zolgensma

SMA

clinical trials

Spinal Muscular Atrophy: Four trials to watch over the next 12 months

Clinical Trials Arena

Fri, 08/11/23 - 11:39 am

clinical trials

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

CP Wire

Sun, 03/26/23 - 03:44 pm

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Sun, 03/26/23 - 03:36 pm

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

NASDAQ

Mon, 03/20/23 - 04:47 pm

EMA weighs new safety guidance for Novartis’ gene therapy Zolgensma

BioPharma Dive

Tue, 01/17/23 - 10:26 am

Novartis cuts 275 jobs at Illinois site to consolidate Zolgensma manufacturing in North Carolina

Endpoints

Wed, 11/9/22 - 11:13 pm

Novartis sales of Zolgensma gene therapy slow as market shifts

BioPharma Dive

Tue, 10/25/22 - 11:02 pm

gene therapy

SMA

Gene therapy is saving lives, but key challenges to realize its full potential

MedCity News

Thu, 10/20/22 - 10:30 am

Novartis' Zolgensma Under Fire Again as Nature Retracts 2010 Paper

BioSpace

Wed, 10/12/22 - 11:45 pm

Novartis reports deaths of two patients treated with Zolgensma gene therapy

BioPharma Dive

Thu, 08/11/22 - 11:32 pm

Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies

Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?

Motley Fool

Mon, 05/2/22 - 11:57 am

The Medicines Company

Levqio

Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy

Fierce Biotech

Wed, 04/27/22 - 10:51 pm

Endpoints

Tue, 04/5/22 - 11:33 pm

New Data Reinforces Impact of Novartis' Gene Therapy on SMA

BioSpace

Mon, 03/14/22 - 10:46 am

gene therapy

Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects

Fierce Biotech

Tue, 10/26/21 - 10:41 am

Novartis has negotiated Zolgensma access for half of the European SMA population, exec says. How'd it get there?

Fierce Pharma

Fri, 10/22/21 - 12:39 pm

Zolgensma patent spat brews between Novartis and Regenxbio as top Novartis gene therapy exec departs

Endpoints

Mon, 09/20/21 - 11:15 am

Novartis to launch new Zolgensma trial after FDA lifts restriction

Reuters

Tue, 08/3/21 - 11:01 am

Novartis touts latest Zolgensma data as SMA competition against Biogen, Roche heats up

Fierce Pharma

Sun, 06/20/21 - 10:21 pm

SMA